Company Filing History:
2 out of 891 
2 out of 1,835 
Years Active: 2011-2013
Title: Bernardo Boris Vargaftig: Innovator in Immunology
Introduction
Bernardo Boris Vargaftig is a notable inventor based in Paris, France. He has made significant contributions to the field of immunology, particularly through his innovative work involving Gram positive bacteria. With a total of 2 patents, Vargaftig's research focuses on the treatment of diseases associated with immune dysregulation.
Latest Patents
Vargaftig's latest patents include compositions that utilize Gram positive bacteria for therapeutic purposes. One of his patents describes "Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation." This application relates to compositions that include components prepared from Gram positive facultative intracellular bacteria, aimed at treating disorders involving immune dysregulation in both humans and animals. Another patent elaborates on similar compositions, emphasizing the use of extended freeze-dried killed Gram positive bacteria, including mycobacteria, for the prevention and treatment of disorders such as cancer, autoimmune diseases, allergies, and tuberculosis.
Career Highlights
Throughout his career, Vargaftig has worked with prestigious institutions such as the Institut Pasteur and the Institut National de la Santé et de la Recherche Médicale. His research has been pivotal in advancing our understanding of immune responses and developing novel therapeutic strategies.
Collaborations
Vargaftig has collaborated with esteemed colleagues, including Marie-Anne Nahori and Micheline Lagranderie. These partnerships have further enriched his research endeavors and contributed to the scientific community.
Conclusion
Bernardo Boris Vargaftig's innovative work in immunology, particularly through his patents on Gram positive bacteria, showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against diseases related to immune dysregulation.